Logo Elsevier

EsteéoconteúdodeClinicalSkills

PADRONIZAR COMPETÊNCIAS PARA O CUIDADO CONSISTENTE

Saiba mais sobre Clinical Skills hoje! Padronizar educação e competência de gerenciamento entre enfermeiros, terapeutas e outros profissionais de saúde para assegurar o conhecimento e as habilidades são atuais e refletem as melhores práticas e as diretrizes clínicas mais recentes.

Apr.29.2021
Baixar a checklist

Mechanical Ventilation: High-Frequency Oscillatory Ventilation (Pediatric) - CE

ALERT

Potential complications of high-frequency oscillatory ventilation (HFOV) include hemodynamic compromise, barotrauma, inadequate humidification, endotracheal (ET) tube obstruction, and intraventricular hemorrhage in the neonate.

Asymmetric chest rise may indicate a pneumothorax.

Refer to the American Heart Association (AHA) interim guidelines for resuscitation of the patient with coronavirus disease 2019 (COVID-19) or a person under investigation (PUI) (Box 1)Box 1.undefined#ref3">3

OVERVIEW

Several modes of high-frequency ventilation (HFV) are available. Modes are described by the delivery method and classified by the exhalation mechanism (active or passive). HFOV is the most commonly used mode of HFV.

HFOV delivers a smaller tidal volume (VT) than conventional ventilation, usually less than or equal to the anatomic dead space volume. This decreased VT decreases barotrauma and allows for healing of the lung tissue. With HFOV, oxygenation and elimination of carbon dioxide occur as long as the lung is inflated.4 Alveolar recruitment continues for several hours after HFOV therapy begins, and arterial partial pressure of carbon dioxide (PaCO2) values may initially climb.

Clinical indications for HFOV include:

  • Diffuse alveolar disease, including hyaline membrane disease, acute respiratory distress syndrome, systemic inflammatory response syndrome, and pneumonia4
  • Air leak syndromes, including pulmonary interstitial emphysema and persistent pneumothoraces4
  • Congenital diaphragmatic hernia and pulmonary hypoplasia
  • Focal disease, including meconium aspiration syndrome
  • Failure of conventional ventilation to provide adequate ventilatory support

HFOV is used in the treatment of acute lung injury and acute respiratory distress. The goal of HFOV is to provide respiratory support while avoiding the alveoli stretching and barotrauma that occurs with conventional ventilation. HFOV provides lung protection to pediatric patients with deteriorating gas exchange who require increased ventilatory support.

  • HFOV is produced by a piston pump or a diaphragm with ventilation at a frequency of 600 to 900 breaths per minute,4 which creates positive and negative pressure swings. HFOV does not produce bulk gas delivery. It uses a continuous gas flow to eliminate carbon dioxide and deliver oxygen to the alveoli.
  • Oxygenation is primarily controlled by mean airway pressure (mPaw) and fraction of inspired oxygen (FIO2) concentration. The mPaw can be adjusted with a change in the bias flow or the mPaw adjust control.
  • In HFOV, inspiration and expiration are active. The gas is pushed in and out of the lungs by the piston or oscillating diaphragm.4
  • During HFOV, the pediatric patient exhibits a chest wiggle factor. A chest wiggle that extends to the umbilicus for infants, the iliac crest for children, and the midthigh for adolescents is recommended.

Essential terms include:

  • Frequency (F): Mechanical rate measured in hertz (Hz); 1 Hz = 60 breaths/min;5 settings in infants and children can be 4 to 15 Hz.5
  • Mean airway pressure (mPaw): The average airway pressure over one minute, and is affected by changes in positive end-expiratory pressure (PEEP), peak inspiratory pressure (PIP), inspiratory time and respiratory rate.2
  • Amplitude: The circuit-measured change in pressure (ΔP) generated across the mPaw.
  • Anatomic dead space: Volume of gas in the conducting airways, trachea to terminal bronchioles, where no gas exchange occurs.
  • Inspiratory time (Ti): Time spent in the inspiratory phase of the ventilatory cycle.
  • Attenuation: Reduction of force or magnitude of pressure delivered to pediatric patient.
  • Bias flow: Constant stream of gas through airways created by rapid movements of piston diaphragm.
  • Chest wiggle: The body wiggle or vibration caused by HFV.
  • Power: The electrical current control that displaces the diaphragm-sealed piston; as the piston is displaced in a forward and backward square-wave pattern, amplitude fluctuations are superimposed.
  • Tidal volume (VT): Volume of gas for each breath.
  • Alveolar ventilation: (VT) × (F).

Potential complications of HFOV include:

  • Hemodynamic compromise
  • Barotrauma from excessive air trapping
  • Inadequate humidification
  • Intraventricular hemorrhage in the neonate
  • ET tube obstruction

EDUCATION

  • Provide developmentally and culturally appropriate education based on the desire for knowledge, readiness to learn, and overall neurologic and psychosocial state.
  • Explain that HFOV offers respiratory support and lung protection by providing small breaths at a very fast rate while the patient’s lungs are kept open to a constant airway pressure; that the practitioner can adjust oxygenation or ventilation; and that this procedure carries some risks, including the possibility of lung overdistention.
  • Explain the assessments necessary during HFOV.
  • Provide the family with descriptions and explanations of equipment alarms.
  • Explain that the procedure frequently results in discomfort for the patient and that analgesic and sedative medications may be used to minimize the patient’s pain and anxiety during the procedure.
  • Encourage questions and answer them as they arise.

ASSESSMENT AND PREPARATION

Assessment

  1. Perform hand hygiene before patient contact. Don appropriate personal protective equipment (PPE) based on patient’s need for isolation precautions or risk of exposure to bodily fluids.
  2. Introduce yourself to the patient and family.
  3. Verify the correct patient using two identifiers.
  4. Assess the patient’s developmental level and ability to interact.
  5. Assess the patient’s and family’s understanding of the reasons for and the risks and benefits of the procedure.
  6. Assess the patient’s vital signs, respiratory status, and cardiovascular stability, including intravascular volume.
  7. Assess the patient’s level of consciousness.
  8. Assess the patient’s skin integrity.
  9. Observe the patient for signs of pain and anxiety.

Preparation

  1. Note the baseline arterial blood gas (ABG) values before the initiation of HFOV.
  2. Ensure that a chest radiograph has been evaluated before the initiation of HFOV.

PROCEDURE

  1. Perform hand hygiene and don gloves. Don additional PPE based on the patient’s need for isolation precautions or the risk of exposure to bodily fluids.
  2. Verify the correct patient using two identifiers.
  3. Explain the procedure to the patient and family and ensure that they agree to treatment.
  4. Obtain the correct ventilator based on the patient’s size, as determined by the practitioner and respiratory therapist.
  5. Ensure that the patient is connected to cardiopulmonary, peripheral oxygen saturation (SpO2), and transcutaneous carbon dioxide (TcCO2) monitors.
    Rationale: Monitoring indicates the adequacy of ventilation and signs and symptoms of complications and allows the nurse to respond immediately to changes in carbon dioxide and oxygenation levels.
  6. Review the prescribed ventilator settings and compare them with the appropriate guidelines for HFOV.
  7. Suction the patient’s ET tube to ensure tube patency before starting therapy.
  8. Administer the prescribed analgesic, sedative, and neuromuscular blockade medications.
    Rationale: Analgesia, sedation, and neuromuscular blockade should be adjusted to adequate levels before the start of HFOV.
    Administer the minimal dose of paralytic agent necessary to achieve the desired effect.
  9. Reassess the patient’s pain status, allowing for sufficient onset of action per medication, route, and the patient’s condition.
  10. Calibrate the circuit and complete performance verification.
    Rationale: Proper function of the ventilator must be demonstrated before initiation.
  11. Establish ventilator settings as prescribed.
    1. Activate the oscillator by pushing the Start-Stop button.
      Watch for a green light-emitting diode (LED), which signifies that the oscillator is enabled.
    2. Set the bias flow.
      Rationale: Bias flow provides fresh gas to the circuit and enhances carbon dioxide clearance. Bias flow works interchangeably with the mPaw; the knob should be adjusted to establish the set mPaw.
      Readjust the mPaw after changes in bias flow to prevent inadequate or impeded clearance.
      Rationale: If the bias flow is less than the oscillatory flow, carbon dioxide clearance will be inadequate, reducing the ventilation effect while increasing the pressure differential to high levels (amplitude). If bias flow is greater than oscillatory flow, carbon dioxide clearance may be impeded.
    3. Set the mPaw and increase it as prescribed until an adequate SpO2 value is achieved.
      Rationale: The goal is maximum alveolar recruitment without overdistention of the lungs. The mPaw is adjusted to maintain optimal lung volume. The mPaw can fluctuate with temperature and humidity changes. Lung volumes reach equilibrium slowly in response to changes in ventilator pressure.
    4. Set the frequency.
      Rationale: Frequency is the secondary control for ventilation, and it depends on the patient’s weight.
      Frequency usually needs no adjustment after the rate has been established.
      Rationale: Frequency is not weaned as in conventional ventilation. A decrease in frequency causes an increase in volume displacement, which would decrease the Pa CO 2 level. Too high a frequency may cause an elevated Pa CO 2 because of small volume displacement (less than anatomic dead space).
    5. Set the power control and adjust it as prescribed while observing amplitude and chest wiggle.
      Rationale: Adjusting the power control changes the piston displacement, which in turn affects the amplitude. Amplitude is the primary control for ventilation. 5
      Look for an adequate chest wiggle to establish the appropriate amplitude.
    6. Set the inspiratory time using an inspiratory-to-expiratory (I:E) ratio of 1:2.
    7. Set the FIO2 as low as possible. Once the FIO2 has been decreased, reevaluate lung volume to determine whether mPaw can be decreased.
      Rationale: Adjusting the F IO 2 to the lowest possible level is the goal of therapy. Permissive hypoxemia may be acceptable in some pediatric patients with certain conditions.
      The inability to wean FIO2 after stable ventilator settings have been established may indicate poor lung expansion or HFOV failure.
    8. Set the humidification to achieve the desired proximal airway temperature.
      Rationale: The use of heat and humidity with mechanical ventilation is necessary to prevent damage to the mucosa of the respiratory system. Adequate humidification keeps secretions from becoming thick and sticky.
    9. Set the ventilator alarms.
      Rationale: Ventilator alarms protect the patient from injury and prevent equipment damage.
      Set pulse oximeter alarms at a narrow range.
      Rationale: Loss of pressure in the circuit causes an audible and visual alarm.
  12. Position the patient and the circuit to avoid pressure areas, prevent pulling on tubing, and promote ventilator function.
    Rationale: Proper positioning reduces the risk of skin breakdown from immobilization and promotes airway stability.
  13. Discard supplies, remove PPE, and perform hand hygiene.
  14. Document the procedure in the patient’s record.

MONITORING AND CARE

  1. Ensure that a chest radiograph is obtained and evaluated at prescribed intervals. Do not stop the piston during the radiograph.
    Rationale: Reviewing chest radiographs assists in the evaluation of lung volume. Inadequate lung volume inhibits optimal gas exchange.
    Reportable condition: Inadequate lung volume as evidenced by chest radiograph
  2. Monitor and adjust ventilator settings on the basis of treatment strategies.
    Rationale: Maintaining appropriate ventilator support assists in the evaluation of lung volume.
    Reportable condition: Significant changes in mPaw
  3. Evaluate chest wiggle, especially after each change in the patient’s position.
    Rationale: Evaluation of chest wiggle alerts the nurse or respiratory therapist to changes in the patient’s lung compliance. Changes in chest wiggle may indicate mucus plugging, dislocation of the ET tube, or pneumothorax.
    Reportable condition: Significant changes in chest wiggle
  4. Monitor cardiac function, including heart sounds, heart rate, blood pressure, and perfusion. To complete an adequate assessment of heart sounds, stop the piston by pressing the Start-Stop button.
    Rationale: The patient is especially at risk for hypotension when mPaw is high and hypovolemia or cardiac dysfunction is present.
    Reportable conditions: Tachycardia; hypotension; poor perfusion, including cool extremities and changes in skin color
  5. Monitor respiratory status, including work of breathing and chest auscultation, to assess the symmetry of breath sounds. Note the intensity of the piston.
    Rationale: Changes in the symmetry of the chest or intensity of the piston could indicate changes in lung compliance, mucus plugging, ET tube dislodgment, or pneumothorax.
    Reportable conditions: Tachycardia, increased work of breathing, cyanosis, asymmetric chest movement, decreased SpO2 level, significant change in breath sounds, significant change in intensity of piston
  6. Evaluate ABG values at prescribed intervals and as needed with changes in clinical condition or ventilator parameters.
    Rationale: The ABG analysis provides quantitative measurements of carbon dioxide and oxygen levels.
    Reportable condition: Significant changes from previous ABG levels
  7. Monitor continuous noninvasive respiratory values, including SpO2 and TcCO2.
    Rationale: Noninvasive monitoring provides continuous evaluation of oxygenation and ventilation. Weaning the F IO 2 is often based on the Sp O 2.
    Reportable condition: Significant changes in TcCO2 and SpO2
  8. Suction the ET tube. Stop the piston during the procedure and then restart.
    Rationale: Inline suctioning (without breaking into the circuit to cause derecruitment) establishes airway patency, ET tube patency, and lung recruitment and removes secretions.
    Do not disconnect the patient from the HFOV to perform open suctioning.
    Reportable conditions: Inability to clear secretions, deteriorating respiratory status
  9. Assess, treat, and reassess pain.
  10. Reposition the patient as tolerated.
    Rationale: Pediatric patients are at risk for developing skin breakdown from immobilization.
    Reportable condition: Breakdown of skin integrity
  11. Monitor humidity to ensure adequate airway humidification.
    Rationale: Adequate humidification is necessary to prevent mucosal damage. Inadequate humidification can cause problems with mucus plugging and decreased chest wiggle, which decrease ventilation.
    Reportable condition: Mucus plugs that result in decreased ventilation

EXPECTED OUTCOMES

  • Adequate ventilation and oxygenation
  • Improved alveolar recruitment as evidenced by improved lung expansion
  • Improved respiratory function
  • Hemodynamic stability
  • No infection
  • Adequate airway humidification
  • HFOV instituted without injury to airway, lungs, or skin
  • Intact skin integrity

UNEXPECTED OUTCOMES

  • Inadequate ventilation and oxygenation
  • Lung overinflation or air leak syndrome: pneumothorax, pneumomediastinum, pneumoperitoneum, subcutaneous emphysema
  • Intraventricular hemorrhage (in a neonate)
  • Hemodynamic instability
  • Ventilator-associated pneumonia
  • Tenacious sputum
  • ET tube obstruction
  • Barotrauma
  • Alteration in skin integrity

DOCUMENTATION

  • Cardiopulmonary assessment, including vital signs, chest sounds, and TcCO2 and ABG values
  • Date and time HFOV initiated
  • Ventilator settings, including FIO2, mode, frequency, mPaw, power, amplitude, Ti, and bias flow
  • Assessment of chest wiggle
  • Characteristics of ET tube secretions
  • Patient’s response to the procedure
  • Pain assessment and specific interventions provided
  • Unexpected outcomes and related interventions
  • Education

REFERENCES

  1. Batey, N., Bustani, P. (2020). Neonatal high-frequency oscillatory ventilation. Paediatrics and Child Health, 30(4), 149-153. doi:10.1016/j.paed.2020.01.006
  2. Chipman, D.W. (2021). Chapter 54: Neonatal and pediatric respiratory care. In R.M. Kacmarek, J.K. Stoller, A.J. Heuer (Eds.), Egan’s fundamentals of respiratory care (12th ed., pp. 1212-1241). St. Louis: Elsevier.
  3. Edelson, D.P. and others. (2020). Interim guidance for basic and advanced life support in adults, children, and neonates with suspected or confirmed COVID-19: From the Emergency Cardiovascular Care Committee and Get with the Guidelines-Resuscitation Adult and Pediatric Task Forces of the American Heart Association. Circulation, 141(25), e933-e943. doi:10.1161/CIRCULATIONAHA.120.047463 Retrieved March 11, 2021, from https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.120.047463 (Level VII)
  4. Kornecki, A., Singh, R.N. (2019). Chapter 38: Acute respiratory distress syndrome. In R.W. Wilmott and others (Eds.), Kendig's disorders of the respiratory tract in children (9th ed., pp. 606-614). Philadelphia: Elsevier.
  5. Walsh, B.K., Chatburn, R.L. (2019). Chapter 17: Invasive mechanical ventilation of the neonate and pediatric patient. In B. Walsh, and others (Eds.), Neonatal and pediatric respiratory care (5th ed., pp. 302-337). St. Louis: Elsevier.

Elsevier Skills Levels of Evidence

  • Level I - Systematic review of all relevant randomized controlled trials
  • Level II - At least one well-designed randomized controlled trial
  • Level III - Well-designed controlled trials without randomization
  • Level IV - Well-designed case-controlled or cohort studies
  • Level V - Descriptive or qualitative studies
  • Level VI - Single descriptive or qualitative study
  • Level VII - Authority opinion or expert committee reports
;